Updates

Explore Medicines360’s latest news and resources

Blog

Measuring Our Impact

When women can access affordable contraception, they can live their best and fullest lives. As part of our pioneering non-profit pharmaceutical business model, Medicines360 makes its product available at a  price substantially below the 340B ceiling price set by statute to clinics participating in the 340B Drug Pricing Program. A key component of measuring our […]

Read More >
Blog

Pioneering the Nonprofit Pharmaceutical Industry

Medicines360 is a nonprofit women’s health pharmaceutical company in San Francisco. As a nonprofit, we answer to our mission: to remove cost as a barrier to health by developing and providing quality, affordable women’s health products. We were founded in 2009 and brought our first product to the U.S. market in 2015. We’re proud of […]

Read More >
Blog

Medicines360 Commemorates World Contraception Day 2019

As Medicines360 commemorates World Contraception Day 2019, we recognize the work we’ve done and the work we have left to do. Too many women in the U.S. and across the globe still have difficulty accessing the full range of contraceptive options to live their lives on their own terms. In addition to improving contraceptive access […]

Read More >
Blog

Medicines360 Welcomes Margot Fahnestock as Vice President of Strategic Development

Medicines360 is delighted to announce that Margot Fahnestock has joined our team as Vice President of Strategic Development.  Margot will be responsible for planning, organizing, and implementing all of our high-impact strategic programming and fundraising efforts both in the U.S. and globally. Before Medicines360, Margot served as a Program Officer in the William and Flora […]

Read More >
Blog

Medicines360 Statement on Title X Rule Change

As the leading nonprofit pharmaceutical company addressing women’s most pressing health needs, Medicines360 has continuously and strongly opposed the new rule restricting Title X-funded clinics from providing patients with medically accurate and comprehensive health information. Our concerns about this rule’s impact on the availability, accessibility and affordability of quality women’s health and family planning services […]

Read More >

FEATURED UPDATES

News

International Women’s Day at Direct Relief International

SANTA BARBARA INDEPENDENT – Direct Relief’s Kirchmaier Volunteer Center was standing room only Friday morning, March 8, as more than 150 people gathered in honor of International Women’s Day to celebrate achievements and acknowledge remaining hurdles, including the lack of global access to affordable maternal health care. This year’s theme was “balance for better — […]

Read More >
Press Releases

Medicines360, Afaxys Partner to Expand Public Health Access to LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg

Strategic alliance will increase engagement with U.S. public health clinics and their patients about hormonal IUDs (long-acting reversible contraceptives, or LARCs) SAN FRANCISCO and CHARLESTON, S.C. – Medicines360 and Afaxys Pharma, LLC, two mission-driven, socially conscious women’s health pharmaceutical companies, today announced their collaboration to promote Medicines360’s intrauterine system (IUS), LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg, which is […]

Read More >
News

Medicines360 Expands Access To Contraception In Africa

FORBES – Medicines360, the non-profit pharmaceutical company behind the hormonal IUD Liletta, is on a mission to increase women’s access to reproductive care around the world. This month, the female-led company announced the launch of Avibela, a hormonal IUD, in Madagascar.

Read More >